Figure 1
From: Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERĪ±-positive breast cancer
KaplanāMeier survival curves according to the combination of LLGL2 and SLC7A5 mRNA expression. Graphs show DFS and OS curves for all breast cancer patients (a,b), ERĪ±-positive breast cancer patients (c,d), ERĪ±-positive breast cancer patients receiving adjuvant tamoxifen therapy (e,f), and ERĪ±-negative breast cancer patients (g,h).
